An interventional study of Cognitive stress tests during functional MRI and Cognitive stress tests during gait task in Alzheimer Disease, sponsored by Duke University. Completed at 1 site in United States. Open to participants aged 58 Years to 70 Years. Per ClinicalTrials.gov, last updated 2017-08-14.
Sponsored by Duke University · Not applicable, Interventional, and Diagnostic
The purpose of this study is to test whether two new cognitive "stress tests" may help distinguish between people at lower or higher genetic risk of Alzheimer's Disease. The investigators are trying to understand how these cognitive "stress tests" work in people who have not been diagnosed with Alzheimer's Disease and are not exhibiting symptoms of Alzheimer's Disease. Study subjects will undergo testing of memory and executive function during functional magnetic resonance image (fMRI) of the brain and also during a walking test.
The objective is to establish the feasibility and evaluate the role of two novel tests of cognitive resilience for use in identification of early Alzheimer's Disease. The investigators hypothesize that exposure to the controlled stressor of increased cognitive task demand will evoke measurable phenotypes of poor resilience, which will be associated with Alzheimer's Disease risk. The study will include 30 volunteer participants from the Duke Alzheimer's Disease Prevention Registry (ADPR). The ADPR cohort has been characterized according to genetic risk based on genotype at loci associated with Alzheimer's Disease. The investigators will recruit a sample from the ADPR that includes 15 people in the "genetic high risk" group and 15 people, matched by age, in the "genetic low risk" group. Investigators and experimenters are masked to the genetic profile of all participants. All participants will undergo two cognitive stress test protocols. Both protocols include memory and executive function components, one done during functional MRI and one while ambulating on a force sensor mat. Both cognitive stress tests are minimal risk; the primary risk of this study is loss of confidentiality. Genetic testing is not performed as part of this protocol; the sampling strategy will make use of prior genetic testing results, which are not revealed to the primary investigators. In addition to determining whether scores on the two novel tests statistically differ by AD risk groups, the project will establish the tests' feasibility and characteristics for use in future study.
3,678 studies on the registry are indexed under Alzheimer Disease; 872 are open to participants now.
This study's enrollment of 29 is below the median of 70 across 2,808 interventional studies indexed under Alzheimer Disease.
Browse Alzheimer Disease studies →Duke University is the lead sponsor of 2,025 studies on the registry; 275 are open to participants now.
Of its 194 completed or terminated interventional studies of FDA-regulated products, 159 (82%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
This group includes subjects with APOEe4 homozygotes, the genetic profile associated with the highest risk for late-onset AD and the next highest-risk group, APOE e3/e4 heterozygotes. To target the highest risk among the APOEe3/e4 heterozygotes in ADPR, the study team will consider TOMM40-'523 variant status. Although there is uncertainty about the independent role of TOMM40 in AD risk-stratification (especially across racial/ethnic groups), this study will use TOMM40-'523 to guide heterozygote selection based on findings that among e3/e4 heterozygotes, longer TOMM40-523 polyT sequences are associated with earlier age of onset for late-onset AD.
Other: Cognitive stress tests during functional MRI · Other: Cognitive stress tests during gait task
This group includes e2/e2 homozygotes (rare) and e2/e3 heterozygotes. the genetic profile associated with low risk for late-onset development of Alzheimer's disease.
Other: Cognitive stress tests during functional MRI · Other: Cognitive stress tests during gait task
Subjects will undergo progressively more complex cognitive stress tests that assess memory and executive function while undergoing fMRI.
Subjects will undergo progressively more complex cognitive stress tests that assess memory and executive function both in sitting and while ambulating on a force sensor mat.
Change in reaction time during memory testing during fMRI
The primary dependent variable will be change in reaction time when comparing a neutral memory task to a stress condition. Reaction time will be in ms and will be recorded while the subject is undergoing fMRI.
Time frame: Measured immediately during one hour fMRI
Change in reaction time during executive function testing during fMRI
The primary dependent variable will be change in reaction time when comparing a neutral executive function task to a stress condition. Reaction time will be in ms and will be recorded while the subject is undergoing fMRI.
Time frame: Measured immediately during one hour fMRI
Change in accuracy during memory testing during gait task
The primary dependent variable will be DTEcog = (Dual task \[cognitive score\] - Single Task \[cognitive score\] / Single task \[cognitive score\]. For the memory task, the primary cognitive measure will be the number of correct responses.
Time frame: Measured immediately during one hour gait session
Change in reaction time during executive function testing during gait task
The primary dependent variable will be DTEcog = (Dual task \[cognitive score\] - Single Task \[cognitive score\] / Single task \[cognitive score\]. For the executive task, the primary cognitive measure in the DTEcog calculation will be reaction time.
Time frame: Measured immediately during one hour gait session
Change in accuracy during memory testing during fMRI
Secondary dependent variables are accuracy (% correct) when comparing a neutral memory task to a stress condition.
Time frame: Measured immediately during one hour fMRI
Change in accuracy during executive function testing during fMRI
Secondary dependent variables are accuracy (% correct) when comparing a neutral memory task to a stress condition.
Time frame: Measured immediately during one hour fMRI
Brain activation during memory testing during fMRI
Group differences in brain activation provoked by the memory stress condition will be assessed using brain maps that compare block-average BOLD signal for resting vs neutral task, resting vs stress task, neutral vs stress task.
Time frame: Measured immediately during one hour fMRI
Brain activation during executive function testing during fMRI
Group differences in brain activation provoked by the executive function stress condition will be assessed using brain maps that compare block-average BOLD signal for resting vs neutral task, resting vs stress task, neutral vs stress task.
Time frame: Measured immediately during one hour fMRI
Change in gait performance provoked by memory dual tasking
The secondary dependent variable will be DTEmob = (Dual task\[mobility score\] - Single Task\[mobility score\] / Single task \[mobility score\]. For both memory and executive tasks, the mobility measure in the DTEmob calculation will be gait speed.
Time frame: Measured immediately during one hour gait session
Change in gait performance provoked by executive function dual tasking
The secondary dependent variable will be DTEmob = (Dual task\[mobility score\] - Single Task\[mobility score\] / Single task \[mobility score\]. For both memory and executive tasks, the mobility measure in the DTEmob calculation will be gait speed.
Time frame: Measured immediately during one hour gait session
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Duke University